Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 378 DKK -1.18% Market Closed
Market Cap: 88.4B DKK
Have any thoughts about
Genmab A/S?
Write Note

Wall Street
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 2 028.78 DKK with a low forecast of 1 010 DKK and a high forecast of 3 097.5 DKK.

Lowest
Price Target
1 010 DKK
27% Downside
Average
Price Target
2 028.78 DKK
47% Upside
Highest
Price Target
3 097.5 DKK
125% Upside
Genmab A/S Competitors:
Price Targets
ALKS
Alkermes Plc
37% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
29% Upside
4587
PeptiDream Inc
120% Upside
688235
Beigene Ltd
26% Upside
IMMU
Mendus AB (publ)
275% Upside
NGNE
Neurogene Inc
103% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
37% Upside
TH
Theratechnologies Inc
31% Upside

Revenue
Forecast

Revenue Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 8%. The projected CAGR for the next 3 years is 117%.

8%
Past Growth
117%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 0%. The projected CAGR for the next 3 years is 121%.

0%
Past Growth
121%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 0%. The projected CAGR for the next 3 years is 104%.

0%
Past Growth
104%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?
Price Target
2 028.78 DKK

According to Wall Street analysts, the average 1-year price target for GMAB is 2 028.78 DKK with a low forecast of 1 010 DKK and a high forecast of 3 097.5 DKK.

What is Genmab A/S's Revenue forecast?
Projected CAGR
117%

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 8%. The projected CAGR for the next 3 years is 117%.

What is Genmab A/S's Operating Income forecast?
Projected CAGR
121%

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 0%. The projected CAGR for the next 3 years is 121%.

What is Genmab A/S's Net Income forecast?
Projected CAGR
104%

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 0%. The projected CAGR for the next 3 years is 104%.

Back to Top